Caprock Group’s West Pharmaceutical WST Stock Holding History

Caprock Group’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.36M	Buy	+3,785	New	+$1.16M	0.03%	535
2026 Q1	–	Sell	-5,078	Closed	-$1.4M	–	1313
2025 Q4	$1.4M	Sell	5,078 -887	-15%	-$243K	0.03%	500
2025 Q3	$1.47M	Buy	+5,965	New	+$1.45M	0.04%	438
2024 Q4	–	Sell	-901	Closed	-$270K	–	1055
2024 Q3	$270K	Sell	901 -204	-18%	-$62.5K	0.01%	756
2024 Q2	$364K	Buy	1,105 +68	+7%	+$24K	0.01%	627
2024 Q1	$410K	Sell	1,037 -10	-1%	-$3.7K	0.02%	469
2023 Q4	$369K	Sell	1,047 -79	-7%	-$28K	0.02%	478
2023 Q3	$422K	Sell	1,126 -61	-5%	-$23.6K	0.03%	400
2023 Q2	$454K	Buy	1,187 +147	+14%	+$52.5K	0.03%	397
2023 Q1	$360K	Buy	+1,040	New	+$304K	0.03%	442
2022 Q3	–	Sell	-773	Closed	-$234K	–	609
2022 Q2	$234K	Buy	773 +78	+11%	+$25.4K	0.02%	457
2022 Q1	$285K	Buy	695 +113	+19%	+$44.2K	0.03%	443
2021 Q4	$273K	Buy	+582	New	+$251K	0.02%	462

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Caprock Group's WST Position: Q2 2026 in Review

Caprock Group opened a new position in West Pharmaceutical (WST) in Q2 2026: 3,785 shares worth $1.36M. The stake represents 0.03% of the portfolio and ranks #535 among its holdings. This is a return to the name: Caprock Group previously reported a position in WST as recently as Q4 2025.

Caprock Group first reported a position in WST in Q4 2021 and has held it in 13 quarters since. The position peaked at $1.47M in Q3 2025. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Caprock Group held 3,785 shares of West Pharmaceutical worth $1.36M as of Q2 2026.
West Pharmaceutical was a new Caprock Group position in Q2 2026.
West Pharmaceutical made up 0.03% of Caprock Group's portfolio in Q2 2026, its #535 holding.
Caprock Group first reported a position in West Pharmaceutical in Q4 2021 and has held it in 13 quarters since.
Caprock Group's West Pharmaceutical position peaked at $1.47M in Q3 2025.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.